The role of peptide and DNA vaccines in myeloid leukemia immunotherapy

citation_journal_title=Leukemia; citation_title=Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy; citation_author=AS Yong, K Keyvanfar, R Eniafe, BN Savani, K Rezvani, EM Sloand, JM Goldman, AJ Barrett; citation_volume=22; citation_issue=9; citation_publication_date=2008; citation_pages=1721-1727; citation_doi=10.1038/leu.2008.161; citation_id=CR1 citation_journal_title=Exp Hematol Oncol; citation_title=Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011; citation_author=N Ali, SN Adil, MU Shaikh, M Moosajee, N Masood; citation_volume=1; citation_issue=1; citation_publication_date=2012; citation_pages=13; citation_doi=10.1186/2162-3619-1-13; citation_id=CR2 citation_journal_title=J Hematol Oncol; citation_title=Therapeutic advancement of chronic lymphocytic leukemia; citation_author=K Lu, X Wang; citation_volume=5; citation_publication_date=2012; citation_pages=55; citation_doi=10.1186/1756-8722-5-55; citation_id=CR3 citation_journal_title=J Clin Oncol; citation_title=Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation; citation_author=RH Collins, O Shpilberg, WR Drobyski, DL Porter, S Giralt, R Champlin, SA Goodman, SN Wolff, W Hu, C Verfaillie, A List, W Dalton, N Ognoskie, A Chetrit, JH Antin, J Nemunaitis; citation_volume=15; citation_issue=2; citation_publication_date=1997; citation_pages=433-434; citation_id=CR4 citation_journal_title=Blood; citation_title=Chronic myeloid leukemia: current treatment options; citation_author=JM Goldman, BJ Druker; citation_volume=98; citation_issue=7; citation_publication_date=2001; citation_pages=2039-2042; citation_doi=10.1182/blood.V98.7.2039; citation_id=CR5 citation_journal_title=N Engl J Med; citation_title=Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts; citation_author=PL Weiden, N Flournoy, ED Thomas, R Prentice, A Fefer, CD Buckner, R Storb; citation_volume=300; citation_issue=19; citation_publication_date=1979; citation_pages=1068-1073; citation_doi=10.1056/NEJM197905103001902; citation_id=CR6 citation_journal_title=Haematologica; citation_title=Cancer vaccines for patients with acute myeloid leukemia – definition of leukemia-associated antigens and current clinical protocols targeting these antigens; citation_author=J Greiner, H Dohner, M Schmitt; citation_volume=91; citation_issue=12; citation_publication_date=2006; citation_pages=1653-1661; citation_id=CR7 citation_journal_title=Nat Rev Immunol; citation_title=Shaping and reshaping CD8 + T-cell memory; citation_author=JT Harty, VP Badovinac; citation_volume=8; citation_issue=2; citation_publication_date=2008; citation_pages=107-119; citation_doi=10.1038/nri2251; citation_id=CR8 citation_journal_title=Blood; citation_title=Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia; citation_author=C Quintarelli, G Dotti, B De Angelis, V Hoyos, M Mims, L Luciano, HE Heslop, CM Rooney, F Pane, B Savoldo; citation_volume=112; citation_issue=5; citation_publication_date=2008; citation_pages=1876-1885; citation_doi=10.1182/blood-2008-04-150045; citation_id=CR9 citation_journal_title=Haematologica; citation_title=Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies; citation_author=K Rezvani, AS Yong, S Mielke, B Jafarpour, BN Savani, RQ Le, R Eniafe, L Musse, C Boss, R Kurlander, AJ Barrett; citation_volume=96; citation_issue=3; citation_publication_date=2011; citation_pages=432-440; citation_doi=10.3324/haematol.2010.031674; citation_id=CR10 citation_journal_title=Cancer Cell Int; citation_title=New insights into antigen specific immunotherapy for chronic myeloid leukemia; citation_author=Y Li, C Lin, CA Schmidt; citation_volume=12; citation_publication_date=2012; citation_pages=52; citation_doi=10.1186/1475-2867-12-52; citation_id=CR11 citation_journal_title=Curr Opin Immunol; citation_title=DNA vaccines against cancer come of age; citation_author=FK Stevenson, CH Ottensmeier, J Rice; citation_volume=22; citation_issue=2; citation_publication_date=2010; citation_pages=264-270; citation_doi=10.1016/j.coi.2010.01.019; citation_id=CR12 citation_journal_title=Hum Gene Ther; citation_title=DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer; citation_author=L Low, A Mander, K McCann, D Dearnaley, T Tjelle, I Mathiesen, F Stevenson, CH Ottensmeier; citation_volume=20; citation_issue=11; citation_publication_date=2009; citation_pages=1269-1278; citation_doi=10.1089/hum.2009.067; citation_id=CR13 citation_journal_title=Proc Natl Acad Sci U S A; citation_title=DNA vaccines to attack cancer; citation_author=FK Stevenson, CH Ottensmeier, P Johnson, D Zhu, SL Buchan, KJ McCann, JS Roddick, AT King, F McNicholl, N Savelyeva, J Rice; citation_volume=101; citation_issue=Suppl 2; citation_publication_date=2004; citation_pages=14646-14652; citation_doi=10.1073/pnas.0404896101; citation_id=CR14 citation_journal_title=Cancer Res; citation_title=Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients’ tumor cells; citation_author=M Rinaldi, F Ria, P Parrella, E Signori, A Serra, SA Ciafrè, I Vespignani, M Lazzari, MG Farace, G Saglio, VM Fazio; citation_volume=161; citation_issue=4; citation_publication_date=2001; citation_pages=1555-1562; citation_id=CR15 citation_journal_title=Blood; citation_title=Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients; citation_author=JM Timmerman, DK Czerwinski, TA Davis, FJ Hsu, C Benike, ZM Hao, B Taidi, R Rajapaksa, CB Caspar, CY Okada, A van Beckhoven, TM Liles, EG Engleman, R Levy; citation_volume=99; citation_issue=5; citation_publication_date=2002; citation_pages=1517-1526; citation_doi=10.1182/blood.V99.5.1517; citation_id=CR16 citation_journal_title=Immunology; citation_title=Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC; citation_author=HT Maecker, DT Umetsu, RH DeKruyff, S Levy; citation_volume=161; citation_issue=12; citation_publication_date=1998; citation_pages=6532-6536; citation_id=CR17 citation_journal_title=J Immunol; citation_title=The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA; citation_author=K Chan, DJ Lee, A Schubert, CM Tang, B Crain, SP Schoenberger, M Corr; citation_volume=166; citation_issue=5; citation_publication_date=2001; citation_pages=3061-3066; citation_doi=10.4049/jimmunol.166.5.3061; citation_id=CR18 citation_journal_title=Curr Opin Allergy Clin Immunol; citation_title=Adjuvants for immunotherapy; citation_author=O Pfaar, D Cazan, L Klimek, D Larenas-Linnemann, MA Calderon; citation_volume=12; citation_issue=6; citation_publication_date=2012; citation_pages=648-657; citation_doi=10.1097/ACI.0b013e32835a11d6; citation_id=CR19 citation_journal_title=Proc Natl Acad Sci USA; citation_title=Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules; citation_author=Z Wang, MK Choi, T Ban, H Yanai, H Negishi, Y Lu, T Tamura, A Takaoka, K Nishikura, T Taniguchi; citation_volume=105; citation_issue=14; citation_publication_date=2008; citation_pages=5477-5482; citation_doi=10.1073/pnas.0801295105; citation_id=CR20 citation_journal_title=Nat Immunol; citation_title=An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome; citation_author=T Burckstummer, C Baumann, S Bluml, E Dixit, G Durnberger, H Jahn, M Planyavsky, M Bilban, J Colinge, KL Bennett, G Superti-Furga; citation_volume=10; citation_issue=3; citation_publication_date=2009; citation_pages=266-272; citation_doi=10.1038/ni.1702; citation_id=CR21 citation_journal_title=Eur Urol; citation_title=Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial; citation_author=M Mincheff, S Tchakarov, S Zoubak, D Loukinov, C Botev, I Altankova, G Georgiev, S Petrov, HT Meryman; citation_volume=38; citation_issue=2; citation_publication_date=2000; citation_pages=208-217; citation_doi=10.1159/000020281; citation_id=CR22 citation_journal_title=Hum Gene Ther; citation_title=Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen; citation_author=SA Rosenberg, JC Yang, RM Sherry, P Hwu, SL Topalian, DJ Schwartzentruber, NP Restifo, LR Haworth, CA Seipp, LJ Freezer, KE Morton, SA Mavroukakis, DE White; citation_volume=14; citation_issue=8; citation_publication_date=2003; citation_pages=709-714; citation_doi=10.1089/104303403765255110; citation_id=CR23 citation_journal_title=Cancer; citation_title=Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma; citation_author=ST Tagawa, P Lee, J Snively, W Boswell, S Ounpraseuth, S Lee, B Hickingbottom, J Smith, D Johnson, JS Weber; citation_volume=98; citation_issue=1; citation_publication_date=2003; citation_pages=144-154; citation_doi=10.1002/cncr.11462; citation_id=CR24 citation_journal_title=Cancer Res; citation_title=Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma; citation_author=JM Timmerman, G Singh, G Hermanson, P Hobart, DK Czerwinski, B Taidi, R Rajapaksa, CB Caspar, A Van Beckhoven, R Levy; citation_volume=62; citation_issue=20; citation_publication_date=2002; citation_pages=5845-5852; citation_id=CR25 citation_journal_title=J Hematol Oncol; citation_title=Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia; citation_author=X Zha, X Yan, Q Shen, Y Zhang, X Wu, S Chen, B Li, L Yang, S Geng, J Weng, X Du, Y Li; citation_volume=5; citation_publication_date=2012; citation_pages=74; citation_doi=10.1186/1756-8722-5-74; citation_id=CR26 citation_journal_title=Leuk Res; citation_title=BCR-ABL peptide vaccination in healthy subjects: immunological responses are equivalent to those in chronic myeloid leukaemia patients; citation_author=JM Rojas, K Knight, S Watmough, J Bell, L Wang, T Callaghan, RE Clark; citation_volume=35; citation_issue=3; citation_publication_date=2011; citation_pages=369-372; citation_doi=10.1016/j.leukres.2010.05.028; citation_id=CR27 citation_journal_title=Blood; citation_title=A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia; citation_author=K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz, V Zakhaleva, EB Papadopoulos, DA Scheinberg; citation_volume=103; citation_issue=3; citation_publication_date=2004; citation_pages=1037-1042; citation_doi=10.1182/blood-2003-03-0954; citation_id=CR28 citation_journal_title=Lancet; citation_title=Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial; citation_author=M Bocchia, S Gentili, E Abruzzese, A Fanelli, F Iuliano, A Tabilio, M Amabile, F Forconi, A Gozzetti, D Raspadori, S Amadori, F Lauria; citation_volume=365; citation_issue=9460; citation_publication_date=2005; citation_pages=657-662; citation_doi=10.1016/S0140-6736(05)70931-4; citation_id=CR29 citation_journal_title=Leukemia; citation_title=BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes; citation_author=JH Kessler, SA Bres-Vloemans, PA van Veelen, A de Ru, IJ Huijbers, M Camps, A Mulder, R Offringa, JW Drijfhout, OC Leeksma, F Ossendorp, CJ Melief; citation_volume=20; citation_issue=10; citation_publication_date=2006; citation_pages=1738-1750; citation_doi=10.1038/sj.leu.2404354; citation_id=CR30 citation_journal_title=Leukemia; citation_title=A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease; citation_author=PG Maslak, T Dao, M Gomez, S Chanel, J Packin, T Korontsvit, V Zakhaleva, J Pinilla-Ibarz, E Berman, DA Scheinberg; citation_volume=22; citation_issue=8; citation_publication_date=2008; citation_pages=1613-1616; citation_doi=10.1038/leu.2008.7; citation_id=CR31 citation_journal_title=Cancer; citation_title=Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial; citation_author=N Jain, JM Reuben, H Kantarjian, C Li, H Gao, BN Lee, EN Cohen, T Ebarb, DA Scheinberg, J Cortes; citation_volume=115; citation_issue=17; citation_publication_date=2009; citation_pages=3924-3934; citation_doi=10.1002/cncr.24468; citation_id=CR32 citation_journal_title=Br J Haematol; citation_title=Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance; citation_author=M Breccia, M Bocchia, L Cannella, M Defina, M Ippoliti, G Loglisci, M Santopietro, F Lauria, G Alimena; citation_volume=150; citation_issue=2; citation_publication_date=2010; citation_pages=240-242; citation_id=CR33 citation_journal_title=Int J Oncol; citation_title=DNA vaccination against bcr-abl-positive cells in mice; citation_author=V Lucansky, E Sobotkova, R Tachezy, M Duskova, V Vonka; citation_volume=35; citation_issue=4; citation_publication_date=2009; citation_pages=941-951; citation_id=CR34 citation_journal_title=J Exp Clin Cancer Res; citation_title=Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: its applicability for antileukemia immunotherapy; citation_author=Y Osman, M Takahashi, Z Zheng, K Toba, A Liu, T Furukawa, M Narita, Y Aizawa, T Koike, A Shibata; citation_volume=18; citation_issue=4; citation_publication_date=1999; citation_pages=485-492; citation_id=CR35 citation_journal_title=Discov Med; citation_title=Use of animal models for the treatment of leukemias: Efficacy of DNA vaccination combined with ATRA; citation_author=RA Padua, C Chomienne; citation_volume=4; citation_issue=20; citation_publication_date=2004; citation_pages=41-44; citation_id=CR36 citation_journal_title=Nat Med; citation_title=PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia; citation_author=RA Padua, J Larghero, M Robin, C le Pogam, MH Schlageter, S Muszlak, J Fric, R West, P Rousselot, TH Phan, L Mudde, H Teisserenc, AF Carpentier, S Kogan, L Degos, M Pla, JM Bishop, F Stevenson, D Charron, C Chomienne; citation_volume=9; citation_issue=11; citation_publication_date=2003; citation_pages=1413-1417; citation_doi=10.1038/nm949; citation_id=CR37 citation_journal_title=Haematologica; citation_title=Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms; citation_author=JL Pollock, AA Lane, K Schrimpf, TJ Ley; citation_volume=90; citation_issue=8; citation_publication_date=2005; citation_pages=1042-1049; citation_id=CR38 citation_journal_title=Blood; citation_title=DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model; citation_author=K Furugaki, K Pokorna, C Le Pogam, M Aoki, M Reboul, V Bajzik, P Krief, A Janin, ME Noguera, R West, D Charron, C Chomienne, M Pla, H Moins-Teisserenc, RA Padua; citation_volume=115; citation_issue=3; citation_publication_date=2010; citation_pages=653-656; citation_doi=10.1182/blood-2007-08-109009; citation_id=CR39 citation_journal_title=Curr Med Chem; citation_title=Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers; citation_author=Y Oka, A Tsuboi, M Kawakami, OA Elisseeva, H Nakajima, K Udaka, I Kawase, Y Oji, H Sugiyama; citation_volume=13; citation_issue=20; citation_publication_date=2006; citation_pages=2345-2352; citation_doi=10.2174/092986706777935104; citation_id=CR40 citation_journal_title=J Immunother; citation_title=“Wilms Tumor Protein 1” (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow; citation_author=S Ochsenreither, A Fusi, A Busse, S Bauer, C Scheibenbogen, D Stather, E Thiel, U Keilholz, A Letsch; citation_volume=34; citation_issue=1; citation_publication_date=2011; citation_pages=85-91; citation_doi=10.1097/CJI.0b013e3181f3cc5c; citation_id=CR41 citation_journal_title=Cancer Immunol Immunother; citation_title=Wilms’ tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients; citation_author=S Ochsenreither, A Fusi, A Geikowski, D Stather, A Busse, A Stroux, A Letsch, U Keilholz; citation_volume=61; citation_issue=3; citation_publication_date=2012; citation_pages=313-322; citation_doi=10.1007/s00262-011-1099-y; citation_id=CR42 citation_journal_title=Eur J Haematol; citation_title=WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient; citation_author=Y Oji, Y Oka, S Nishida, A Tsuboi, M Kawakami, T Shirakata, K Takahashi, A Murao, H Nakajima, M Narita, M Takahashi, S Morita, J Sakamoto, T Tanaka, I Kawase, N Hosen, H Sugiyama; citation_volume=85; citation_issue=4; citation_publication_date=2010; citation_pages=358-360; citation_doi=10.1111/j.1600-0609.2010.01497.x; citation_id=CR43 citation_journal_title=Med Oncol; citation_title=WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval; citation_author=A Saitoh, M Narita, N Watanabe, N Tochiki, A Yamahira, T Nakamura, M Kaji, M Masuko, T Furukawa, K Toba, I Fuse, Y Aizawa, M Takahashi; citation_volume=28; citation_issue=1; citation_publication_date=2011; citation_pages=219-230; citation_doi=10.1007/s12032-010-9425-3; citation_id=CR44 citation_journal_title=J Clin Immunol; citation_title=Cytotoxic T-lymphocyte responses elicited to Wilms’ tumor gene WT1 product by DNA vaccination; citation_author=A Tsuboi, Y Oka, H Ogawa, OA Elisseeva, H Li, K Kawasaki, K Aozasa, T Kishimoto, K Udaka, H Sugiyama; citation_volume=20; citation_issue=3; citation_publication_date=2000; citation_pages=195-202; citation_doi=10.1023/A:1006637529995; citation_id=CR45 citation_journal_title=Blood; citation_title=DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance; citation_author=C Chaise, SL Buchan, J Rice, J Marquet, H Rouard, M Kuentz, GE Vittes, V Molinier-Frenkel, JP Farcet, HJ Stauss, MH Delfau-Larue, FK Stevenson; citation_volume=112; citation_issue=7; citation_publication_date=2008; citation_pages=2956-2964; citation_doi=10.1182/blood-2008-02-137695; citation_id=CR46 citation_journal_title=Int J Cancer; citation_title=mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies; citation_author=J Greiner, M Ringhoffer, M Taniguchi, L Li, A Schmitt, H Shiku, H Döhner, M Schmitt; citation_volume=108; citation_issue=5; citation_publication_date=2004; citation_pages=704-711; citation_doi=10.1002/ijc.11623; citation_id=CR47 citation_journal_title=Blood; citation_title=High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells; citation_author=C Quintarelli, G Dotti, ST Hasan, B De Angelis, V Hoyos, S Errichiello, M Mims, L Luciano, J Shafer, AM Leen, HE Heslop, CM Rooney, F Pane, MK Brenner, B Savoldo; citation_volume=117; citation_issue=12; citation_publication_date=2011; citation_pages=3353-3362; citation_doi=10.1182/blood-2010-08-300376; citation_id=CR48 citation_journal_title=Blood; citation_title=Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells; citation_author=J Molldrem, S Dermime, K Parker, YZ Jiang, D Mavroudis, N Hensel, P Fukushima, AJ Barrett; citation_volume=88; citation_issue=7; citation_publication_date=1996; citation_pages=2450-2457; citation_id=CR49 citation_journal_title=Blood; citation_title=Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia [abstract]; citation_author=MH Qazilbash, E Wieder, R Rios, S Lu, S Kant, S Giralt, EH Estey, P Thall, M de Lima, D Couriel, RE Champlin, K Komanduri, JJ Molldrem; citation_volume=104; citation_publication_date=2004; citation_pages=259; citation_id=CR50 citation_journal_title=Blood; citation_title=Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies; citation_author=K Rezvani, AS Yong, S Mielke, BN Savani, L Musse, J Superata, B Jafarpour, C Boss, AJ Barrett; citation_volume=111; citation_issue=1; citation_publication_date=2008; citation_pages=236-242; citation_doi=10.1182/blood-2007-08-108241; citation_id=CR51 citation_journal_title=Haematologica; citation_title=High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma; citation_author=J Greiner, A Schmitt, K Giannopoulos, MT Rojewski, M Götz, I Funk, M Ringhoffer, D Bunjes, S Hofmann, G Ritter, H Döhner, M Schmitt; citation_volume=95; citation_issue=7; citation_publication_date=2010; citation_pages=1191-1197; citation_doi=10.3324/haematol.2009.014704; citation_id=CR52 citation_journal_title=Ann Hematol; citation_title=In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival; citation_author=A Tzankov, U Strasser, S Dirnhofer, T Menter, C Arber, M Jotterand, A Rovo, A Tichelli, R Stauder, U Günthert; citation_volume=90; citation_issue=8; citation_publication_date=2011; citation_pages=901-909; citation_doi=10.1007/s00277-011-1159-6; citation_id=CR53 citation_journal_title=Clin Cancer Res; citation_title=Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia; citation_author=Z Li, Y Qiao, B Liu, EJ Laska, P Chakravarthi, JM Kulko, RD Bona, M Fang, U Hegde, V Moyo, SH Tannenbaum, A Ménoret, J Gaffney, L Glynn, CD Runowicz, PK Srivastava; citation_volume=11; citation_issue=12; citation_publication_date=2005; citation_pages=4460-4468; citation_doi=10.1158/1078-0432.CCR-05-0250; citation_id=CR54 citation_journal_title=J Hematol Oncol; citation_title=A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome; citation_author=G Wei, W Ni, JW Chiao, Z Cai, H Huang, D Liu; citation_volume=4; citation_publication_date=2011; citation_pages=46; citation_doi=10.1186/1756-8722-4-46; citation_id=CR55 citation_journal_title=Blood; citation_title=A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS; citation_author=U Keilholz, A Letsch, A Busse, AM Asemissen, S Bauer, IW Blau, WK Hofmann, L Uharek, E Thiel, C Scheibenbogen; citation_volume=113; citation_issue=26; citation_publication_date=2009; citation_pages=6541-6548; citation_doi=10.1182/blood-2009-02-202598; citation_id=CR56 citation_journal_title=Hematology; citation_title=Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARalpha and hIL-2 genes; citation_author=D Cen, G Hu, Y Zhou, L Yang, S Chen, CA Schmidt, Y Li; citation_volume=15; citation_issue=2; citation_publication_date=2010; citation_pages=88-95; citation_doi=10.1179/102453310X125833470096589073; citation_id=CR57 citation_journal_title=Zhonghua Zhong Liu Za Zhi; citation_title=Immune protective mechanisms of gene vaccines with co-expressing bcr-abl fusion gene fragment and mouse IL-7 gene; citation_author=MC Ji, YW Jiang, W Liu, J Guan, L Qian, WJ Gong; citation_volume=29; citation_issue=2; citation_publication_date=2007; citation_pages=93-95; citation_id=CR58 citation_journal_title=Cancer Biol Ther; citation_title=Enhancement of specific cellular immune response induced by glycosyl-phosphatidylinositol-anchored BCR/ABL and mIL-12; citation_author=K Tao, YJ Li, D Wang, JY Qi, YP Deng, HX Wang, J Hu, WL Feng; citation_volume=12; citation_issue=10; citation_publication_date=2011; citation_pages=881-887; citation_doi=10.4161/cbt.12.10.17674; citation_id=CR59 citation_journal_title=Clin Dev Immunol; citation_title=Systemic administration of CpG oligodeoxynucleotide and levamisole as adjuvants for gene-gun-delivered antitumor DNA vaccines; citation_author=M Šmahel, I Poláková, E Sobotková, E Vajdová; citation_volume=2011; citation_publication_date=2011; citation_pages=176759; citation_id=CR60 citation_journal_title=Mol Immunol; citation_title=Simultaneous immunisation with a Wilms’ tumour 1 epitope and its ubiquitin fusions results in enhanced cell mediated immunity and tumour rejection in C57BL/6 mice; citation_author=NS Eslami, MA Shokrgozar, A Mousavi, K Azadmanesh, A Nomani, V Apostolopoulos, S Day, A Amanzadeh, MH Alimohammadian; citation_volume=51; citation_issue=3–4; citation_publication_date=2012; citation_pages=325-331; citation_doi=10.1016/j.molimm.2012.03.033; citation_id=CR61 citation_journal_title=J Int Med Res; citation_title=Antileukaemia immunity: effect of exosomes against NB4 acute promyelocytic leukaemia cells; citation_author=C Shen, SG Hao, CX Zhao, J Zhu, C Wang; citation_volume=39; citation_issue=3; citation_publication_date=2011; citation_pages=740-747; citation_doi=10.1177/147323001103900305; citation_id=CR62 citation_journal_title=Immunol Rev; citation_title=DNA vaccines: an historical perspective and view to the future; citation_author=MA Liu; citation_volume=239; citation_issue=1; citation_publication_date=2011; citation_pages=62-84; citation_doi=10.1111/j.1600-065X.2010.00980.x; citation_id=CR63 citation_journal_title=Cancer Res; citation_title=Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice; citation_author=E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, C De Giovanni, M Spadaro, C Curcio, PL Lollini, P Musiani, G Forni, F Cavallo; citation_volume=64; citation_issue=8; citation_publication_date=2004; citation_pages=2858-2864; citation_doi=10.1158/0008-5472.CAN-03-2962; citation_id=CR64 citation_journal_title=Cancer Gene Ther; citation_title=DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice; citation_author=C Curcio, AS Khan, A Amici, M Spadaro, E Quaglino, F Cavallo, G Forni, R Draghia-Akli; citation_volume=15; citation_issue=2; citation_publication_date=2008; citation_pages=108-114; citation_doi=10.1038/sj.cgt.7701106; citation_id=CR65 citation_journal_title=Vaccine; citation_title=Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection; citation_author=YK Cheung, SC Cheng, FW Sin, Y Xie; citation_volume=23; citation_issue=5; citation_publication_date=2004; citation_pages=629-638; citation_doi=10.1016/j.vaccine.2004.07.010; citation_id=CR66